Non-invasive Coronary Imaging Market Size & Growth Forecast 2027–2036, By Segments (End-use, Modality), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Non-invasive Coronary Imaging Market size was more than USD 464.5 million in 2026 and is set to grow at a 6.27% CAGR between 2027 and 2036, surpassing USD 853.28 million by 2036. The industry revenue for 2027 is assessed at USD 489.03 million.
Get more details on this report
Request Free Sample ReportNon-invasive Coronary Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 40.28% of the market in 2026, supported by advanced imaging infrastructure, routine cardiovascular assessments, high equipment utilization, and established clinical adoption across healthcare settings.
- Asia Pacific is projected to grow at a 7.57% CAGR, driven by expanding healthcare infrastructure, wider adoption of advanced cardiac diagnostics, and increasing demand for scalable coronary evaluation services.
Segment Momentum
- Hospitals accounted for 45.16% of the market in 2026 because cardiac imaging is integrated into routine diagnostics, emergency care, cardiology services, and comprehensive patient management workflows.
- Radionuclide cardiac imaging is the fastest-growing modality due to increasing demand for myocardial perfusion assessment and more targeted physiological evaluation in complex coronary diagnostic pathways.
Market Expansion Drivers
- Rising cardiovascular disease prevalence and aging population driving non-invasive diagnostic demand.
- AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy.
- Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures.
Leading Market Participants
- Leading companies in the non-invasive coronary imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Shimadzu Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Esaote S.p.A. (Italy), Samsung Medison Co., Ltd. (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 464.5 million
- 2027 Estimated Market Size: USD 489.03 million.
- Projected Market Size: USD 853.28 million by 2036
- Growth Forecast: 6.27% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Echocardiography (Modality)
- Emerging Opportunity Segment: Research Institute (End-use) | Radionuclide Cardiac Imaging (Modality)
Market Growth Drivers and Industry Trends
Rising cardiovascular disease prevalence and aging population driving non-invasive diagnostic demand
Increasing cardiovascular disease burden alongside population aging is creating greater demand for diagnostic approaches that can evaluate coronary health without requiring invasive procedures, supporting the non-invasive coronary imaging market. Older adults often require closer cardiovascular assessment because age is associated with a higher risk of coronary abnormalities and related complications, while the broader prevalence of cardiovascular risk factors is increasing the need for earlier evaluation. Non-invasive imaging techniques can provide clinicians with detailed information about coronary anatomy and cardiac function while avoiding the procedural risks associated with catheter-based diagnostic approaches. Greater emphasis on early detection and risk assessment is encouraging healthcare providers to incorporate advanced imaging into cardiovascular diagnostic pathways.
AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy
Advances in artificial intelligence and high-resolution imaging technologies are enhancing the non-invasive coronary imaging market by improving the interpretation, visualization, and assessment of coronary abnormalities. AI-based tools can assist clinicians in analyzing complex imaging data, identifying subtle patterns, and supporting more consistent interpretation, while higher-resolution imaging can provide clearer views of coronary structures and disease-related changes. These capabilities can help improve diagnostic confidence and support earlier identification of conditions that may otherwise be difficult to characterize. Integration of intelligent image analysis with advanced diagnostic systems is also helping streamline clinical workflows by assisting healthcare professionals in processing increasingly complex cardiovascular imaging information.
Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures
Broader reimbursement support for advanced cardiovascular diagnostic procedures is improving patient access to sophisticated imaging services and will drive the non-invasive coronary imaging market growth by reducing financial barriers to medically indicated examinations. When insurers provide coverage for appropriate cardiac imaging, healthcare providers have greater scope to recommend advanced diagnostic procedures based on clinical requirements rather than relying primarily on lower-cost alternatives. Improved reimbursement environments can also encourage hospitals and diagnostic centers to invest in imaging capabilities and related infrastructure, increasing the availability of specialized cardiac assessment. Greater coverage can therefore support wider utilization among patients requiring detailed coronary evaluation while strengthening integration of non-invasive imaging into routine cardiovascular care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular disease prevalence and aging population driving non-invasive diagnostic demand | 2.60% | High | North America, Europe, Asia Pacific | High | Near Term |
| AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy | 2.30% | High | North America, Europe, Asia Pacific | Medium | Mid Term |
| Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures | 2.10% | High | North America, Europe | High | Near Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America dominated the non-invasive coronary imaging market with a 40.28% share in 2026, supported by advanced healthcare infrastructure, widespread access to sophisticated diagnostic technologies, and strong emphasis on early detection of cardiovascular conditions. Growing demand for diagnostic approaches that can provide detailed coronary assessment without invasive procedures is encouraging the use of advanced imaging modalities in clinical practice. The region's established network of hospitals and specialty care centers, together with continued investment in medical imaging capabilities, facilitates adoption. Increasing focus on preventive cardiovascular care and improving diagnostic accuracy further strengthens demand for non-invasive coronary imaging.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest growth in the non-invasive coronary imaging market as healthcare infrastructure expands and awareness of cardiovascular disease management increases. Rising demand for advanced diagnostic services is encouraging hospitals and imaging centers to adopt technologies that can support earlier and more efficient assessment of coronary conditions. Improvements in healthcare access, increasing investment in medical equipment, and the expansion of specialized cardiac care are creating favorable conditions for adoption. In addition, growing awareness of preventive healthcare and the need to manage cardiovascular risk are expected to increase demand for non-invasive diagnostic solutions across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany prioritizes non-invasive coronary imaging systems that deliver high-resolution visualization and standardized diagnostic performance. Healthcare institutions in Germany invest in technology upgrades that support efficient cardiovascular assessment and evidence-based clinical practice.
France 🇫🇷
Integrated Cardiac DiagnosticsFrance supports non-invasive coronary imaging through coordinated cardiovascular care and continued modernization of diagnostic capabilities. Healthcare providers in France focus on improving imaging efficiency while expanding access to advanced cardiac assessment technologies.
Italy 🇮🇹
Hospital Imaging ModernizationItaly continues strengthening non-invasive coronary imaging through modernization of hospital imaging capabilities and broader adoption of advanced diagnostic systems. Medical centers in Italy prioritize reliable imaging performance and efficient cardiovascular evaluation within routine clinical practice.
Japan 🇯🇵
High-Resolution Imaging FocusJapan emphasizes non-invasive coronary imaging solutions capable of delivering precise cardiovascular visualization with efficient patient workflows. Medical providers in Japan continue adopting advanced imaging technologies that support early assessment and optimized diagnostic decision-making.
South Korea 🇰🇷
Digital Cardiology AdoptionSouth Korea integrates non-invasive coronary imaging with digitally connected healthcare infrastructure and advanced diagnostic practices. Hospitals in South Korea emphasize efficient imaging workflows and technology-enabled cardiovascular evaluation to enhance patient management.
United States 🇺🇸
Advanced Diagnostic IntegrationThe U.S. non-invasive coronary imaging market emphasizes advanced imaging technologies that improve diagnostic accuracy and clinical workflow efficiency. Healthcare providers in the U.S. continue integrating AI-assisted interpretation and modern imaging platforms into cardiovascular care pathways.
Segment Leadership and Growth Trends
Non-invasive Coronary Imaging Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Research Institute (Fastest-Growing Segment)
Hospitals held the largest share of the non-invasive coronary imaging market, accounting for 45.16% in 2026. Their leading position is supported by the high volume of cardiovascular diagnostic procedures performed in hospital settings and the availability of specialized imaging infrastructure and multidisciplinary cardiac care. Hospitals are equipped to integrate non-invasive imaging into routine patient assessment, emergency evaluation, and long-term cardiovascular disease management. The growing emphasis on early diagnosis, reduced procedural risk, and efficient clinical decision-making further strengthens demand for advanced coronary imaging technologies across hospital networks.
Research institutes are expected to be the fastest-growing end-use segment, driven by expanding cardiovascular research and increasing efforts to improve imaging techniques for the detection and assessment of coronary conditions. These institutions play an important role in evaluating novel imaging approaches, developing advanced analytical methods, and generating clinical evidence to support technological innovation. Growing collaboration between research organizations, healthcare providers, and technology developers is further supporting the adoption of sophisticated non-invasive imaging systems within research environments.
Modality Segment Analysis: Echocardiography (Largest Segment) vs Radionuclide Cardiac Imaging (Fastest-Growing Segment)
Echocardiography dominated the modality segment of the non-invasive coronary imaging market with a 35.09% share in 2026. Its widespread adoption is driven by its non-invasive nature, broad clinical availability, and ability to provide real-time information on cardiac structure and function. The modality is commonly incorporated into cardiovascular assessment because it can support routine diagnostic workflows without exposing patients to ionizing radiation. Continued improvements in imaging quality and the growing use of advanced echocardiographic techniques are also reinforcing its central role in cardiac evaluation.
Radionuclide cardiac imaging is anticipated to be the fastest-growing modality segment as healthcare providers increasingly seek detailed functional information to support the diagnosis and management of coronary disease. Its ability to assess myocardial perfusion and identify abnormalities in blood flow makes it valuable for evaluating complex cardiovascular conditions. Advances in imaging systems, radiopharmaceutical techniques, and diagnostic protocols are improving clinical utility and supporting broader adoption, particularly where comprehensive functional assessment is required.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Diagnostic Imaging Centers, Research Institute | Hospitals | Research Institute |
| Modality | Radionuclide Cardiac Imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging | Echocardiography | Radionuclide Cardiac Imaging |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Major players in the non-invasive coronary imaging market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Fujifilm Holdings Corporation (Japan)
6. United Imaging Healthcare Co. Ltd. (China)
7. Shimadzu Corporation (Japan)
8. Neusoft Medical Systems Co. Ltd. (China)
9. Esaote S.p.A. (Italy)
10. Samsung Medison Co. Ltd. (South Korea)
The non-invasive coronary imaging market is progressing through innovations that enhance imaging precision and early cardiovascular disease detection. Research activities focused on faster scanning technologies and improved diagnostic accuracy are supporting greater adoption across modern healthcare settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Fujifilm Holdings Corporation (Japan) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| Shimadzu Corporation (Japan) | |||||||
| Neusoft Medical Systems Co. Ltd. (China) | |||||||
| Esaote S.p.A. (Italy) | |||||||
| Samsung Medison Co. Ltd. (South Korea). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Shanghai United Imaging Healthcare | Jul-24 | Shanghai United Imaging Healthcare (UIH) completed the installation of its first PET/CT scanner at the Instituto Nacional de Pediatría in Mexico. This deployment represents a strategic geographic expansion into the Latin American medical imaging market, establishing a local clinical footprint for UIH’s high-end molecular imaging technology and enhancing regional access to advanced, non-invasive diagnostic capabilities for pediatric oncology and cardiovascular assessment. |
| Philips | Feb-24 | Philips launched the CT 5300 system, an advanced X-ray CT platform integrated with AI-driven diagnostic and workflow tools. Designed for high-throughput environments, the system enhances diagnostic precision and system uptime for cardiovascular imaging, streamlining clinical procedures and reducing operational bottlenecks in radiology and interventional departments through automated image reconstruction and dose management. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Non-invasive Coronary Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Coronary Artery Disease Diagnosis, Ischemia Assessment, Cardiac Risk Assessment, Treatment Planning & Follow-Up |
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay, Mixed Reimbursement |
| Purchasing Model | Direct Capital Purchase, Equipment Leasing, Pay-Per-Use & Service-Based Models |
Non-invasive Coronary Imaging Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Barrier Assessment |
|
| Healthcare Provider Workflow Integration |
|
| AI-Enabled Imaging Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow big is the non-invasive coronary imaging market?
What is the expected industry size of non-invasive coronary imaging by 2036?
How is the need for earlier cardiac assessment driving adoption of non-invasive coronary imaging?
How are AI capabilities improving operational adoption of non-invasive coronary imaging technologies?
Why are hospitals the largest end-use segment in the non-invasive coronary imaging market?
What is driving growth in radionuclide cardiac imaging within the non-invasive coronary imaging market?
Why is North America the largest market for non-invasive coronary imaging?
What factors are accelerating the non-invasive coronary imaging market in Asia Pacific?
Who are the major participants shaping the non-invasive coronary imaging landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization